Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
GD2-GD3 Vaccine
i
Other names:
GD2-GD3 Vaccine, adjuvant OPT-821 in a vaccine containing two antigens (GD2L and GD3L) covalently linked to KLH, MV-NB-02
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
BioNTech, Memorial Sloan-Kettering Cancer Center, Y-mAbs Therap
Drug class:
GD2 ganglioside inhibitor, GD3 ganglioside inhibitor
Related drugs:
‹
dinutuximab beta (2)
naxitamab-gqgk (1)
dinutuximab (1)
BCD-245 (0)
TRBS07 (0)
GD2-SADA (0)
KUR-501 (0)
Hu14.18K322A (0)
APN301 (0)
GD2xCD3 (0)
dinutuximab beta (2)
naxitamab-gqgk (1)
dinutuximab (1)
BCD-245 (0)
TRBS07 (0)
GD2-SADA (0)
KUR-501 (0)
Hu14.18K322A (0)
APN301 (0)
GD2xCD3 (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login